50 mg/kg of cyclophosphamide on day 3, 4

2 trials

Sponsors

Chiba Shigeru, University of Tsukuba

Conditions

AML, ALL, NHL, MDSAML, ALL, NHL. MDS

Phase 1

Phase I/II study of HSCT from HLA-matched donor using post-transplant cyclophosphamide

Active, not recruitingJPRN-UMIN000028779

University of TsukubaAML, ALL, NHL. MDS

Start: 2017-11-01Target: 20Updated: 2026-06-29

Phase 2

HLA-matched PT/CY

Active, not recruitingJPRN-jRCTs031180140

Chiba ShigeruAML, ALL, NHL, MDS

Start: 2018-10-09Target: 20Updated: 2026-06-29